Wimmer Associates 1’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.49M Sell
10,175
-74
-0.7% -$17.2K 1.22% 21
2025
Q4
$2.12M Sell
10,249
-179
-2% -$35.4K 0.99% 29
2025
Q3
$1.93M Hold
10,428
0.93% 29
2025
Q2
$1.59M Sell
10,428
-155
-1% -$23.8K 0.81% 31
2025
Q1
$1.57M Sell
10,583
-137
-1% -$21.4K 0.83% 31
2024
Q4
$1.55M Sell
10,720
-10
-0.1% -$1.55K 0.77% 31
2024
Q3
$1.74M Hold
10,730
0.85% 30
2024
Q2
$1.57M Sell
10,730
-222
-2% -$33K 0.8% 32
2024
Q1
$1.73M Sell
10,952
-106
-1% -$16.9K 0.91% 31
2023
Q4
$1.73M Buy
11,058
+110
+1% +$16.9K 0.98% 31
2023
Q3
$1.71M Sell
10,948
-664
-6% -$110K 1.06% 30
2023
Q2
$1.92M Sell
11,612
-80
-0.7% -$12.9K 1.16% 27
2023
Q1
$1.87M Sell
11,692
-159
-1% -$25.7K 1.19% 27
2022
Q4
$2.09M Sell
11,851
-45
-0.4% -$7.77K 1.38% 25
2022
Q3
$2.07M Sell
11,896
-170
-1% -$28.8K 1.37% 25
2022
Q2
$2.14M Sell
12,066
-39
-0.3% -$6.95K 1.4% 25
2022
Q1
$2.15M Sell
12,105
-70
-0.6% -$11.9K 1.19% 27
2021
Q4
$2.08M Sell
12,175
-191
-2% -$31.3K 1.12% 29
2021
Q3
$2M Buy
12,366
+44
+0.4% +$7.51K 1.18% 25
2021
Q2
$2.03M Sell
12,322
-153
-1% -$25.3K 1.19% 26
2021
Q1
$2.05M Sell
12,475
-747
-6% -$121K 1.12% 26
2020
Q4
$2.08M Buy
13,222
+329
+3% +$48.5K 1.24% 22
2020
Q3
$1.92M Buy
12,893
+410
+3% +$60.7K 1.29% 27
2020
Q2
$1.85M Sell
12,483
-329
-3% -$47.9K 1.44% 23
2020
Q1
$1.68M Buy
12,812
+1,058
+9% +$150K 1.56% 23
2019
Q4
$1.72M Sell
11,754
-255
-2% -$34.6K 1.37% 26
2019
Q3
$1.55M Sell
12,009
-2,294
-16% -$302K 1.36% 28
2019
Q2
$1.99M Sell
14,303
-65
-0.5% -$9K 1.74% 21
2019
Q1
$2.01M Sell
14,368
-464
-3% -$62.2K 1.78% 19
2018
Q4
$1.91M Sell
14,832
-2,083
-12% -$291K 1.9% 16
2018
Q3
$2.34M Sell
16,915
-83
-0.5% -$11K 1.94% 13
2018
Q2
$2.06M Buy
16,998
+50
+0.3% +$6.24K 1.84% 16
2018
Q1
$2.17M Sell
16,948
-259
-2% -$35K 1.91% 15
2017
Q4
$2.4M Sell
17,207
-79
-0.5% -$11K 2.16% 10
2017
Q3
$2.25M Sell
17,286
-1,694
-9% -$225K 2.07% 10
2017
Q2
$2.51M Sell
18,980
-889
-4% -$113K 2.31% 8
2017
Q1
$2.48M Sell
19,869
-1,554
-7% -$186K 2.31% 8
2016
Q4
$2.47M Sell
21,423
-598
-3% -$69.1K 2.29% 8
2016
Q3
$2.6M Sell
22,021
-961
-4% -$117K 2.34% 7
2016
Q2
$2.79M Sell
22,982
-683
-3% -$77.6K 2.49% 5
2016
Q1
$2.56M Buy
23,665
+2,317
+11% +$240K 2.35% 7
2015
Q4
$2.19M Buy
+21,348
New +$2.15M 2.3% 10

Other funds holding JNJ

Wimmer Associates 1's JNJ Position: Q1 2026 in Review

Wimmer Associates 1 reduced its Johnson & Johnson (JNJ) stake by 0.72% in Q1 2026, selling an estimated $17.2K and leaving 10,175 shares worth $2.49M. The position accounts for 1.22% of the portfolio, ranked #21.

Wimmer Associates 1 first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. The position peaked at $2.79M in Q2 2016. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Wimmer Associates 1 held 10,175 shares of Johnson & Johnson worth $2.49M as of Q1 2026.
  • Wimmer Associates 1 sold 74 Johnson & Johnson shares in Q1 2026, an estimated $17.2K.
  • Johnson & Johnson made up 1.22% of Wimmer Associates 1's portfolio in Q1 2026, its #21 holding.
  • Wimmer Associates 1 first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
  • Wimmer Associates 1's Johnson & Johnson position peaked at $2.79M in Q2 2016.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Wimmer Associates 1's 13F filing for Q1 2026, filed 15 May 2026.